Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Accumulated Expenses (2021 - 2025)

Rxo's Accumulated Expenses history spans 5 years, with the latest figure at $397.0 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 6.43% year-over-year to $397.0 million; the TTM value through Dec 2025 reached $397.0 million, up 6.43%, while the annual FY2025 figure was $397.0 million, 6.43% up from the prior year.
  • Accumulated Expenses reached $397.0 million in Q4 2025 per RXO's latest filing, up from $321.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $397.0 million in Q4 2025 to a low of $197.0 million in Q2 2024.
  • Average Accumulated Expenses over 5 years is $275.1 million, with a median of $262.0 million recorded in 2024.
  • Peak YoY movement for Accumulated Expenses: fell 22.27% in 2023, then soared 87.44% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $248.0 million in 2021, then grew by 3.23% to $256.0 million in 2022, then dropped by 22.27% to $199.0 million in 2023, then skyrocketed by 87.44% to $373.0 million in 2024, then rose by 6.43% to $397.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Accumulated Expenses are $397.0 million (Q4 2025), $321.0 million (Q3 2025), and $315.0 million (Q2 2025).